Drugs Targeting Hereditary Spherocytosis: A Comprehensive Overview
Abstract
Hereditary vspherocytosus ( HS ) is a genetic disorders influencing red blood cells. resulting in a specific spherical shape and an enhanced fragility. One of the essential approach in managing Hereditary spherocytosis is particularly folate supplementation. Folate plays an important role especially in red blood cell production and assists in mitigating the effects of anemia related to HS. By providing an essential component of DNA synthesis, folate is involved in the formation of healthy red blood cells. In a very cases. especially if HS results in severe anemia, immuno suppressive therapy may be taken into consideration. Drugs namely corticosteroids can assists in reducing the immune systems activity, decreasing the destruction of red blood cells. Whatever it may be, the use of immuno suppressive drugs needs careful consideration of potential side effects. Erythropoietin ( EPO ) is a hormone that activates the production of especially red blood cells in the bone marrow. While not a direct treatment for Hereditary spherocyrosis, EPO may be used to address anemia related to the condition. It is often considered in cases where other interventions are insufficient or contra indicated. In severe instances of Hereditary spherocytosis, especially when anemia is life_ threatening or causing significant impairment, blood transfusions may be required. Transfusions arrange ca temporary solution by replacing the damaged red blood cells with healthy ones. Splenectomy ir elimination of spleen, is a definitive treatment for Hereditary spherocytosis. The spleen is responsible for the destruction of especially abnormally -shaped red blood cells and it's elimination can alleviate many symptoms. Whatever it may be, post_ Splenectomy, individuals are at an enhanced risk of infections, necessitating vaccination and antibiotic prophylaxis. Finally it is concluded that while drugs are bit a curative option for Hereditary spherocytosis, they play an important role in managing symptoms and complications.
Full Text:
PDFReferences
Manciu S, Matei E, Trandafir B. Hereditary Spherocytosis - Diagnosis, Surgical Treatment and Outcomes. A Literature Review. Chirurgia (Bucur). 2017 Mar-Apr;112(2):110-116. [PubMed]
Narla J, Mohandas N. Red cell membrane disorders. Int J Lab Hematol. 2017 May;39 Suppl 1:47-52. [PubMed]
Mariani M, Barcellini W, Vercellati C, Marcello AP, Fermo E, Pedotti P, Boschetti C, Zanella A. Clinical and hematologic features of 300 patients affected by hereditary spherocytosis grouped according to the type of the membrane protein defect. Haematologica. 2008 Sep;93(9):1310-7. [PubMed]
Comité Nacional de Hematología. Donato H, Crisp RL, Rapetti MC, García E, Attie M. [Hereditary spherocytosis: Review. Part I. History, demographics, pathogenesis, and diagnosis]. Arch Argent Pediatr. 2015 Jan;113(1):69-80. [PubMed]
Ciepiela O. Old and new insights into the diagnosis of hereditary spherocytosis. Ann Transl Med. 2018 Sep;6(17):339. [PMC free article] [PubMed]
Pizzi M, Fuligni F, Santoro L, Sabattini E, Ichino M, De Vito R, Zucchetta P, Colombatti R, Sainati L, Gamba P, Alaggio R. Spleen histology in children with sickle cell disease and hereditary spherocytosis: hints on the disease pathophysiology. Hum Pathol. 2017 Feb;60:95-103. [PubMed]
Comité Nacional de Hematología. Donato H, Crisp RL, Rapetti MC, García E, Attie M. [Hereditary spherocytosis. Review. Part II. Symptomatology, outcome, complications, and treatment]. Arch Argent Pediatr. 2015 Apr;113(2):168-76. [PubMed]
Bolton-Maggs PH, Langer JC, Iolascon A, Tittensor P, King MJ., General Haematology Task Force of the British Committee for Standards in Haematology. Guidelines for the diagnosis and management of hereditary spherocytosis--2011 update. Br J Haematol. 2012 Jan;156(1):37-49. [PubMed]
Christensen RD, Yaish HM, Gallagher PG. A pediatrician's practical guide to diagnosing and treating hereditary spherocytosis in neonates. Pediatrics. 2015 Jun;135(6):1107-14. [PMC free article] [PubMed]
Farias MG. Advances in laboratory diagnosis of hereditary spherocytosis. Clin Chem Lab Med. 2017 Jun 27;55(7):944-948. [PubMed]
Tchernia G, Delhommeau F, Perrotta S, Cynober T, Bader-Meunier B, Nobili B, Rohrlich P, Salomon JL, Sagot-Bevenot S, del Giudice EM, Delaunay J, DeMattia D, Schischmanoff PO, Mohandas N, Iolascon A., ESPHI working group on hemolytic anemias. Recombinant erythropoietin therapy as an alternative to blood transfusions in infants with hereditary spherocytosis. Hematol J. 2000;1(3):146-52. [PubMed]
Agre P, Asimos A, Casella JF, McMillan C. Inheritance pattern and clinical response to splenectomy as a reflection of erythrocyte spectrin deficiency in hereditary spherocytosis. N Engl J Med. 1986 Dec 18;315(25):1579-83. [PubMed]
Andolfo I, Russo R, Gambale A, Iolascon A. Hereditary stomatocytosis: An underdiagnosed condition. Am J Hematol. 2018 Jan;93(1):107-121. [PubMed]
Niss O, Chonat S, Dagaonkar N, Almansoori MO, Kerr K, Rogers ZR, McGann PT, Quarmyne MO, Risinger M, Zhang K, Kalfa TA. Genotype-phenotype correlations in hereditary elliptocytosis and hereditary pyropoikilocytosis. Blood Cells Mol Dis. 2016 Oct;61:4-9. [PMC free article] [PubMed]
Liebman HA, Weitz IC. Autoimmune Hemolytic Anemia. Med Clin North Am. 2017 Mar;101(2):351-359. [PubMed]
Becheur M, Bouslama B, Slama H, Toumi NE. [Autoimmune hemolytic anemia in children]. Transfus Clin Biol. 2015 Oct-Dec;22(5-6):291-8. [PubMed]
Krueger HC, Burgert EO. Hereditary spherocytosis in 100 children. Mayo Clin Proc. 1966 Dec;41(12):821-30. [PubMed]
Tamary H, Aviner S, Freud E, Miskin H, Krasnov T, Schwarz M, Yaniv I. High incidence of early cholelithiasis detected by ultrasonography in children and young adults with hereditary spherocytosis. J Pediatr Hematol Oncol. 2003 Dec;25(12):952-4. [PubMed]
Kaymak Cihan M, Gökçe H, Oruç M, Olcay L. Hemolytic crisis as the initial presentation of hereditary spherocytosis induced by parvovirus b19 and herpes virus infection in a patient with the thalassemia trait: a case report. Turk J Haematol. 2012 Dec;29(4):425-6. [PMC free article] [PubMed]
Kobayashi Y, Hatta Y, Ishiwatari Y, Kanno H, Takei M. Human parvovirus B19-induced aplastic crisis in an adult patient with hereditary spherocytosis: a case report and review of the literature. BMC Res Notes. 2014 Mar 11;7:137. [PMC free article] [PubMed]
Refbacks
- There are currently no refbacks.